natgillin/translations-raw huggingface dataset:
Adverse reactions reported in excess (> 0.5%) of placebo and as more than an isolated case in patients receiving pioglitazone in double-blind studies are listed below as MedDRA preferred term by system organ class and absolute frequency.
Nuspojave koje su bile zabilježene češće (> 0,5%) nego uz placebo ili kao izolirani slučaj u bolesnika koji su primali pioglitazon u dvostruko slijepim ispitivanjima navedene su niže prema MedDRA pojmovima, klasifikaciji organskih sustava i apsolutnoj učestalosti.
In most clinical trials, reduced total plasma triglycerides and free fatty acids, and increased HDL-cholesterol levels were observed as compared to placebo, with small, but not clinically significant increases in LDL-cholesterol levels.
U većini kliničkih ispitivanja primijećeno je sniženje ukupnih triglicerida i slobodnih masnih kiselina u plazmi te povišenje razine HDL-kolesterola u usporedbi s placebom, uz mala ali ne i klinički značajna povišenja razine LDL-kolesterola.
There may be an increased possibility of becoming pregnant because you may ovulate again when you take Actos.
Kad uzimate Actos, možete ponovno imati ovulaciju pa mogućnost trudnoće može biti povećana.
Musculoskeletal and connective tissue disorders fracture bone4
Poremećaji mišićnokoštanog sustava i vezivnog tkiva prijelom kosti4
Takeda UK Ltd Tel: +44 (0)1628 537 900
United Kingdom Takeda UK Ltd Tel: + 44 (0)1628 537 900
Localised swelling (oedema) has also been experienced very commonly (may affect more than 1 in 10 people) in patients taking Actos in combination with insulin.
Lokalizirano oteknuće (edemi) također su vrlo često (mogu se pojaviti kod više od 1 na 10 osoba) nastajali u bolesnika koji su uzimali Actos u kombinaciji s inzulinom.
In the 3.5 year PROactive study, 44/870 (5.1%) of pioglitazone-treated female patients experienced fractures compared to 23/905 (2.5%) of female patients treated with comparator.
U PROactive ispitivanju u trajanju od 3,5 godine, 44/870 (5,1%) bolesnica liječenih pioglitazonom doživjelo je prijelom u usporedbi s 23/905 (2,5%) bolesnica liječenih usporednim lijekom.
The effect of pioglitazone (45 mg monotherapy vs. placebo) was studied in a small 18-week trial in type 2 diabetics.
Učinak pioglitazona (monoterapija dozom od 45 mg naspram placebo) ispitivao se u malom ispitivanju u trajanju od 18 tjedana u bolesnika sa šećernom bolešću tipa
Investigations weight increased6
Pretrage povećana tjelesna težina6
3 In controlled clinical trials the incidence of reports of heart failure with pioglitazone treatment was the same as in placebo, metformin and sulphonylurea treatment groups, but was increased when used in combination therapy with insulin.
U kontroliranim kliničkim ispitivanjima, incidencija prijavljenih zatajenja srca uz liječenje pioglitazonom bila je podjednaka onoj u skupinama koje su primale placebo, metformin ili sulfonilureju, ali povišena kad se pioglitazon primjenjivao u kombiniranoj terapiji s inzulinom.
In a placebo controlled trial, patients with inadequate glycaemic control despite a three month insulin optimisation period were randomised to pioglitazone or placebo for 12 months.
U placebom kontroliranom ispitivanju, bolesnici s neodgovarajućom kontrolom glikemije usprkos tromjesečnog razdoblja optimizacije inzulina bili su randomizacijom raspodijeljeni u skupinu koja je primala pioglitazon odnosno skupinu koja je primala placebo tijekom 12 mjeseci.
Blurred vision due to swelling (or fluid) at the back of the eye has also been reported in patients taking Actos (frequency cannot be estimated from the available data).
U bolesnika koji uzimaju Actos zabilježen je i zamagljen vid zbog oticanja (ili nakupljanja tekućine) na stražnjoj strani oka (učestalost se ne može procijeniti iz dostupnih podataka).
In PROactive, a cardiovascular outcome study, 5,238 patients with type 2 diabetes mellitus and pre-existing major macrovascular disease were randomised to pioglitazone or placebo in addition to existing antidiabetic and cardiovascular therapy, for up to 3.5 years.
U PROactive ispitivanju kardiovaskularnih ishoda, 5238 bolesnika sa šećernom bolešću tipa 2 i postojećom teškom makrovaskularnom bolešću bilo je randomizacijom raspodijeljeno u skupinu koja je primala pioglitazon i onu koja je primala placebo uz postojeću antidijabetičku i kardiovaskularnu terapiju u trajanju do 3,5 godine.
Each tablet contains 114.51 mg of lactose monohydrate (see section 4.4).
Jedna tableta sadrži 114,51 mg laktoza hidrata (vidjeti dio 4.4).
− The active substance in Actos is pioglitazone.
Djelatna tvar Actosa je pioglitazon.
Similar changes were seen in metformin (haemoglobin 3-4% and haematocrit 3.6-4.1% relative reductions) and to a lesser extent sulphonylurea and insulin (haemoglobin 1-2% and haematocrit 1-3.2% relative reductions) treated patients in comparative controlled trials with pioglitazone.
U usporednim kontroliranim ispitivanjima pioglitazona opažene su slične promjene u bolesnika liječenih metforminom (relativno smanjenje hemoglobina za 3-4% i hematokrita za 3,6-4,1%) i u manjoj mjeri u bolesnika liječenih sulfonilurejom i inzulinom (relativno smanjenje hemoglobina za 1-2% i hematokrita za 1-3,2%).
Each tablet contains 92.87 mg of lactose monohydrate (see section 4.4).
Jedna tableta sadrži 92,87 mg laktoza hidrata (vidjeti dio 4.4).
6 In active comparator controlled trials mean weight increase with pioglitazone given as monotherapy was 2-3 kg over one year.
U ispitivanjima kontroliranima aktivnim usporednim lijekom, prosječno povećanje tjelesne težine tijekom monoterapije pioglitazonom iznosilo je 2-3 kg tijekom jedne godine.
Each tablet contains 76.34 mg of lactose monohydrate (see section 4.4).
Jedna tableta sadrži 76,34 mg laktoza hidrata (vidjeti dio 4.4).
Bladder cancer has been experienced uncommonly (may affect up to 1 in 100 people) in patients taking Actos.
Karcinom mokraćnog mjehura manje je često (može se pojaviti u do 1 na 100 osoba) nastao u bolesnika koji uzimaju Actos.
How to store Actos
Kako čuvati Actos
common common common common common blood creatine phospho-kinase increased common increased lactic dehydro-genase uncommon alanine aminotransferase increased7
često često često često često povišena kreatin fosfokinaza u krvi često povišena laktična dehidrogenaza manje često povišena alanin aminotransferaza nepoznato nepoznato nepoznato nepoznato nepoznato
Fasting and postprandial glycaemic control is improved in patients with type 2 diabetes mellitus.
Poboljšava se kontrola glikemije natašte i nakon obroka u bolesnika sa šećernom bolešću tipa
Metabolism and nutrition disorders hypo-glycaemia uncommon very common common appetite increased uncommon
Poremećaji metabolizma i prehrane hipoglikemija manje često vrlo često često pojačan apetit manje često
There was a small reduction in mean haemoglobin (4% relative reduction) and haematocrit (4.1% relative reduction) during therapy with pioglitazone, consistent with haemodilution.
Tijekom terapije pioglitazonom došlo je do malog smanjenja prosječne vrijednosti hemoglobina (relativno smanjenje za 4%) i hematokrita (relativno smanjenje za 4,1%), sukladno hemodiluciji.
4 A pooled analysis was conducted of adverse reactions of bone fractures from randomised, comparator controlled, double blind clinical trials in over 8,100 patients in the pioglitazone-treated groups and 7,400 in the comparator-treated groups of up to 3.5 years duration.
Provedena je analiza objedinjenih podataka o prijelomima kostiju kao nuspojavama u randomiziranim, usporednim lijekom kontroliranim, dvostruko slijepim kliničkim ispitivanjima u više od 8100 bolesnika u skupinama liječenima pioglitazonom i 7400 bolesnika u skupinama liječenima usporednim lijekom u trajanju do 3,5 godine.
Adverse reaction Frequency of adverse reactions of pioglitazone by treatment regimen
Učestalost nuspojava pioglitazona prema režimu liječenja
- if you are allergic to pioglitazone or any of the other ingredients of this medicine (listed in section 6).
Nemojte uzimati Actos - ako ste alergični na pioglitazon ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.). - ako imate zatajenje srca ili ste prije imali zatajenje srca.
Heart failure has been reported with marketing use of pioglitazone, and more frequently when pioglitazone was used in combination with insulin or in patients with a history of cardiac failure (see section 4.4).
Zatajenje srca uz primjenu pioglitazona zabilježeno je nakon stavljanja lijeka u promet, i bilo je češće kad se pioglitazon primjenjivao u kombinaciji s inzulinom ili u bolesnika sa zatajenjem srca u anamnezi (vidjeti dio 4.4).
Allergic reactions have been reported with frequency not known (cannot be estimated from the available data) in patients taking Actos.
Kod bolesnika koji su uzimali Actos prijavljene su alergijske reakcije s nepoznatom učestalosti (ne može se procijeniti iz dostupnih podataka).
Carmellose calcium Hyprolose
Laktoza hidrat
Actos 15 mg tablets Actos 30 mg tablets Actos 45 mg tablets
Actos 15 mg tablete Actos 30 mg tablete Actos 45 mg tablete pioglitazon
Lactose monohydrate Magnesium stearate
Magnezijev stearat
Co-administration of pioglitazone with gemfibrozil (an inhibitor of cytochrome P450 2C8) is reported to result in a 3-fold increase in AUC of pioglitazone.
Zabilježeno je da istodobna primjena pioglitazona s gemfibrozilom (inhibitor citokroma P450 2C8) rezultira trostrukim povećanjem AUC-a pioglitazona.
common (may affect up to 1 in 10 people) - respiratory infection - abnormal vision - weight gain - numbness uncommon (may affect up to 1 in 100 people) - inflammation of the sinuses (sinusitis) - difficulty sleeping (insomnia)
često (mogu se pojaviti u do 1 na 10 osoba) - infekcija dišnih puteva - poremećen vid - povećanje tjelesne težine - utrnulost manje često (mogu se pojaviti u do 1 na 100 osoba)
A higher rate of fractures was observed in women taking pioglitazone (2.6%) versus comparator (1.7%).
Viša stopa prijeloma bila je primijećena u žena koje su uzimale pioglitazon (2,6%) nego usporedni lijek (1,7%).
- if you retain water (fluid retention) or have heart failure problems, in particular if you are over 75 years old.
Upozorenja i mjere opreza Obratite se svom liječniku ili ljekarniku prije nego uzmete Actos (pogledajte također dio 4.) - ako zadržavate vodu (nakupljanje tekućine) ili imate tegobe s zatajivanjem srca, osobito ako ste stariji od 75 godina.
Actos 30 mg tablets
Actos 30 mg tablete
common common uncommon macular oedema not known not known not known not known not known
Poremećaji oka poremećaj vida često često manje često makularni edem nepoznato nepoznato nepoznato nepoznato nepoznato
Takeda Pharma A/S
Nositelj odobrenja za stavljanje lijeka u promet Takeda Pharma A/S
Actos 45 mg tablets
Actos 45 mg tablete
Actos 15 mg tablets
Actos 15 mg tablete
− Actos 45 mg tablets are white to off-white, round, flat tablets marked ‘45' on one face and
Actos 45 mg tablete su bijele do gotovo bijele boje, okrugle, plosnate s oznakom ‘45' na jednoj strani i ‘ACTOS' na drugoj strani.
1 Postmarketing reports of hypersensitivity reactions in patients treated with pioglitazone have been reported.
Nakon stavljanja lijeka na tržište, kod bolesnika koji su liječeni pioglitazonom prijavljeni su slučajevi reakcija preosjetljivosti.
− Actos 30 mg tablets are white to off-white, round, flat tablets marked ‘30' on one face and
Actos 30 mg tablete su bijele do gotovo bijele boje, okrugle, plosnate s oznakom ‘30' na jednoj strani i ‘ACTOS' na drugoj strani.
Infections and infestations upper respiratory tract infection common common common common common bronchitis common sinusitis uncommon uncommon uncommon uncommon uncommon
Infekcije i infestacije infekcije gornjih dišnih puteva često često često često često bronhitis često sinusitis manje često manje često manje često manje često manje često
Read the package leaflet before use.
NAČIN I PUT(EVI) PRIMJENE LIJEKA Prije uporabe pročitati uputu o lijeku.
Each Actos 30 mg tablet contains 30 mg of pioglitazone (as hydrochloride).
Jedna tableta lijeka Actos od 30 mg sadrži 30 mg pioglitazona (u obliku pioglitazonklorida).
EU/1/00/150/015 EU/1/00/150/016 EU/1/00/150/017 EU/1/00/150/018 EU/1/00/150/019 EU/1/00/150/020 EU/1/00/150/021 EU/1/00/150/022 EU/1/00/150/023 EU/1/00/150/024 EU/1/00/150/025 EU/1/00/150/026 EU/1/00/150/027 EU/1/00/150/028 EU/1/00/150/029 EU/1/00/150/030
EU/1/00/150/001 EU/1/00/150/002 EU/1/00/150/003 EU/1/00/150/004 EU/1/00/150/005 EU/1/00/150/006 EU/1/00/150/007 EU/1/00/150/008 EU/1/00/150/009 EU/1/00/150/010 EU/1/00/150/011 EU/1/00/150/012 EU/1/00/150/013 EU/1/00/150/014 EU/1/00/150/015 EU/1/00/150/016 EU/1/00/150/017 EU/1/00/150/018 EU/1/00/150/019 EU/1/00/150/020 EU/1/00/150/021 EU/1/00/150/022 EU/1/00/150/023 EU/1/00/150/024 EU/1/00/150/025 EU/1/00/150/026 EU/1/00/150/027 EU/1/00/150/028 EU/1/00/150/029 EU/1/00/150/030
Respiratory, thoracic and mediastinal disorders dyspnoea common
Poremećaji dišnog sustava, prsišta i sredoprsja dispneja često
Each Actos 45 mg tablet contains 45 mg of pioglitazone (as hydrochloride).
Jedna tableta lijeka Actos od 45 mg sadrži 45 mg pioglitazona (u obliku pioglitazonklorida).
Each Actos 15 mg tablet contains 15 mg of pioglitazone (as hydrochloride).
Jedna tableta lijeka Actos od 15 mg sadrži 15 mg pioglitazona (u obliku pioglitazonklorida).
The tablets are white to off-white, round, flat and marked ‘45' on one face and ‘ACTOS' on the other face.
Tablete su bijele do gotovo bijele boje, okrugle, plosnate i imaju oznaku ‘45' s jedne strane i ‘ACTOS' s druge strane.
Nervous system disorders hypo-aesthesia common common common common common headache common uncommon dizziness common insomnia uncommon uncommon uncommon uncommon uncommon
Poremećaji živčanog sustava hipoestezija često često često često često glavobolja često manje često omaglica često nesanica manje često manje često manje često manje često manje često
EU/1/00/150/011 14 tablets EU/1/00/150/012 28 tablets EU/1/00/150/022 30 tablets EU/1/00/150/013 50 tablets EU/1/00/150/014 56 tablets EU/1/00/150/023 84 tablets EU/1/00/150/024 90 tablets EU/1/00/150/015 98 tablets EU/1/00/150/029 112 tablets EU/1/00/150/030 196 tablets
EU/1/00/150/011 14 tableta EU/1/00/150/012 28 tableta EU/1/00/150/022 30 tableta EU/1/00/150/013 50 tableta EU/1/00/150/014 56 tableta EU/1/00/150/023 84 tableta EU/1/00/150/024 90 tableta EU/1/00/150/015 98 tableta EU/1/00/150/029 112 tableta EU/1/00/150/030 196 tableta
The tablets are white to off-white, round, flat and marked ‘30' on one face and ‘ACTOS' on the other face.
Tablete su bijele do gotovo bijele boje, okrugle, plosnate i imaju oznaku ‘30' s jedne strane i ‘ACTOS' s druge strane.
The tablets are white to off-white, round, convex and marked ‘15' on one face and ‘ACTOS' on the other face.
Tablete su bijele do gotovo bijele boje, okrugle, konveksne i imaju oznaku ‘15' s jedne strane i ‘ACTOS' s druge strane.
Actos 30 mg tablets pioglitazone
NAZIV LIJEKA Actos 30 mg tablete pioglitazon
EU/1/00/150/008 14 tablets EU/1/00/150/004 28 tablets EU/1/00/150/019 30 tablets EU/1/00/150/005 50 tablets EU/1/00/150/010 56 tablets EU/1/00/150/020 84 tablets EU/1/00/150/021 90 tablets EU/1/00/150/006 98 tablets EU/1/00/150/027 112 tablets EU/1/00/150/028 196 tablets
EU/1/00/150/008 14 tableta EU/1/00/150/004 28 tableta EU/1/00/150/019 30 tableta EU/1/00/150/005 50 tableta EU/1/00/150/010 56 tableta EU/1/00/150/020 84 tableta EU/1/00/150/021 90 tableta EU/1/00/150/006 98 tableta EU/1/00/150/027 112 tableta EU/1/00/150/028 196 tableta
EU/1/00/150/007 14 tablets EU/1/00/150/001 28 tablets EU/1/00/150/016 30 tablets EU/1/00/150/002 50 tablets EU/1/00/150/009 56 tablets EU/1/00/150/017 84 tablets EU/1/00/150/018 90 tablets EU/1/00/150/003 98 tablets EU/1/00/150/025 112 tablets EU/1/00/150/026 196 tablets
EU/1/00/150/007 14 tableta EU/1/00/150/001 28 tableta EU/1/00/150/016 30 tableta EU/1/00/150/002 50 tableta EU/1/00/150/009 56 tableta EU/1/00/150/017 84 tableta EU/1/00/150/018 90 tableta EU/1/00/150/003 98 tableta EU/1/00/150/025 112 tableta EU/1/00/150/026 196 tableta
Actos 45 mg tablets pioglitazone
NAZIV LIJEKA Actos 45 mg tablete pioglitazon
Lilly Hungária Kft. Tel: +36 1 328 5100
Tel: + 36 1 328 5100
Contains lactose monohydrate.
POPIS POMOĆNIH TVARI Sadrži laktozu hidrat.
Actos 15 mg tablets pioglitazone
NAZIV LIJEKA Actos 15 mg tablete pioglitazon
Avda.
Nuspojava
− Actos 15 mg tablets are white to off-white, round, convex tablets marked ‘15' on one face and
Kako Actos izgleda i sadržaj pakiranja Actos 15 mg tablete su bijele do gotovo bijele boje, okrugle, konveksne s oznakom ‘15' na jednoj strani i ‘ACTOS' na drugoj strani.
It is not known whether pioglitazone is secreted in human milk.
Nije poznato izlučuje li se pioglitazon u majčino mlijeko pa se stoga pioglitazon ne smije primjenjivati u dojilja.
ANNEX IV SCIENTIFIC CONCLUSIONS AND GROUNDS FOR THE VARIATION TO THE TERMS OF THE MARKETING AUTHORISATION(S)
PRILOG IV. ZNANSTVENI ZAKLJUČCI
Renal and urinary disorders haematuria common glycosuria uncommon proteinuria uncommon
Poremećaji bubrega i mokraćnog sustava hematurija često glikozurija manje često proteinurija manje često
Neoplasms benign, malignant and unspecified (including cysts and polyps)
Dobroćudne, zloćudne i nespecificirane novotvorine (uključujući ciste i polipe) karcinom mokraćnog mjehura manje često manje često manje često manje često manje često
List of the names, pharmaceutical forms, strengths of the medicinal products, route of administration, applicant in the Member States
Popis naziva, farmaceutskih oblika, jačine lijeka, puta primjene i podnositelja zahtjeva u državama članicama
United Kingdom Kohne Pharma GmbH Schallbruch 1
Ujedinjeno Kraljevstvo Kohne Pharma GmbH Schallbruch 1
Capsule, Hard
Kapsula, tvrda
Capsule
Kapsula
Antibiotice Sa
Antibiotice
Annex I List of nationally authorised medicinal products
Prilog I Popis naziva lijekova odobrenih nacionalnim postupkom
Tabletta Analgetica Fono Vii
Tabletata Analgetica Fono Vii
Syrup
Sirup
Intramuscular Use | Intravenous Use
Intramuskularno | intravenski
Solution For Injection/Infusion
Otopina za injekciju/infuziju
Ratiopharm España S.A. Metamizol Ratiopharm Metamizole Magnesium 575mg Capsule
Ratiopharm España S.A. Metamizol Ratiopharm Metamizolmagnezij 575 mg kapsula
Abc Farmaceutici S.P.A. Metamizolo Sodico Abc Metamizole Sodium 500mg/ml
Abc Farmaceutici S.P.A. Metamizolo Sodico Abc Metamizolnatrij 500 mg/ml
Sanofi-Aventis Slovakia Sro
Sanofi-Aventis Slovačka Sro
Chemax Pharma Ltd Диалгин Джуниор Metamizole Sodium Monohydrate 250mg
Chemax Pharma Ltd Диалгин Джуниор Metamizolnatrij hidrat 250 mg vrećica
Meditop Pharmaceutical Co. Ltd.
Meditop Pharmaceutical Co.
Metamizol Sintocalmin Metamizole 500mg Tablet
Metamizol Sintocalmin Metamizol 500 mg tableta
Melting Tablets
Šumeća tableta
Codeine Phosphate Sesquihydrate 0.03g in form of Codeine Phosphate Hemihydrate 0.02873g, Metamizole Sodium 0.9g, Caffeine And Sodium Benzoate 0.1g / suppository
Kodeinfosfat seskvihidrat 0,03 g u obliku kodeinfosfat hemihidrata 0,02873 g; metamizolnatrij 0,9 g; kofein i natrijev benzoat 0,1 g / čepić
Solution For Injection Intramuscular Use
Otopina za injekciju Intramuskularno
Solution For Injection Intravenous Use
Otopina za injekciju Intravenski
G.L.
Ltd.
Metamizole Sodium 500mg Tablet, Triacetonamine Tosilate 20mg Tablet
Metamizolnatrij 500 mg tableta; triacetonamin tosilat 20 mg tableta
Coated Tablet
Obložena tableta
Powder For Oral Solution In Sachet
Prašak za oralnu otopinu u vrećici
Metamizole Sodium 300mg Tablet, Paracetamol 200mg Tablet, Caffeine 30mg Tablet, Codeine Phosphate 20mg Tablet
Metamizolnatrij 300 mg tableta; paracetamol 200 mg tableta; kofein 30 mg tableta; kodeinfosfat 20 mg tableta
Metamizole Sodium 450mg Tablet, Caffeine 50mg Tablet
Metamizolnatrij 450 mg tableta; kofein 50 mg tableta
Hydrochloride 10mg, Metamizole Sodium 1g
Pitofenonklorid 10 mg; metamizolnatrij 1 g
Metamizole Sodium 150mg Tablet, Paracetamol 300mg Tablet, Phenobarbital 15mg Tablet, Caffeine 50mg Tablet, Codeine Phosphate Hemihydrate 10mg Tablet
Metamizolnatrij 150 mg tableta; paracetamol 300 mg tableta; fenobarbital 15 mg tableta; kofein 50 mg tableta; kodeinfosfat hemihidrat 10 mg tableta
Metamizole Sodium 0.9g Suppository, Caffeine 0.05g Suppository, Codeine Phosphate Hemihydrate 0.03g Suppository
Metamizolnatrij 0,9 g čepić; kofein 0,05 g čepić; kodeinfosfat hemihidrat 0,03 g čepić
Buscapina Compositum Metamizole Sodium 250mg Tablet, Hyoscine Butylbromide 10mg
Buscapina Compositum Metamizolnatrij 250 mg tableta; hioscinijev butilbromid 10 mg tableta
Metamizole 500mg/ml
Metamizol 500 mg/ml
Scopolan Compositum Metamizole Sodium 250mg Tablet, Hyoscine Butylbromide 10mg
Scopolan Compositum Metamizolnatrij 250 mg tableta; hioscinijev butilbromid 10 mg tableta
Metamizol Kern Pharma Metamizole Magnesium 575mg Capsule
Metamizol Kern Pharma Metamizolmagnezij 575 mg kapsula
Drotaverine Hydrochloride 40mg Tablet, Metamizole Sodium 400mg Tablet, Caffeine 60mg Tablet
Drotaverinklorid 40 mg tableta; metamizolnatrij 400 mg tableta; kofein 60 mg tableta
Metamizole Sodium Monohydrate 25mg Drop
Metamizolnatrij hidrat 25 mg kapi
Metamizole Sodium Monohydrate 0.525g/ml
Metamizolnatrij hidrat 0,525 g/ml
Metamizole Sodium 0.5g Suppository, Caffeine And Sodium Benzoate 0.1g Suppository
Metamizolnatrij 0,5 g čepić; kofein i natrijev benzoat 0,1 g čepić
Codeine Phosphate Sesquihydrate 0.03g Suppository, Metamizole Sodium 0.09g Suppository, Caffeine And Sodium Benzoate 0.1g Suppository, Codeine Phosphate Hemihydrate 0.02873g Suppository
Kodeinfosfat seskvihidrat 0,03 g čepić; metamizolnatrij 0,09 g čepić; kofein i natrijev benzoat 0,1 g čepić; kodeinfosfat hemihidrat 0,02873 g čepić
Metamizole Magnesium 575mg Tablet
Metamizolmagnezij 575 mg tableta
Pharma Gmbh Metagelan
G.L. Pharma Gmbh Metagelan
Thiamine Hydrochloride 38.75mg Tablet, Metamizole Sodium 500mg Tablet, Caffeine 50mg Tablet
Tiaminklorid 38,75 mg tableta; metamizolnatrij 500 mg tableta; kofein 50 mg tableta
Metamizole Magnesium 1000mg Suppository
Metamizolmagnezij 1000 mg čepić
Metamizole Sodium 1g Suppository
Metamizolnatrij 1 g čepić
Metamizole Sodium 1g/2ml
Metamizolnatrij 1 g/2 ml
Metamizol Normon Metamizole Magnesium 2g/5ml
Metamizol Normon Metamizolmagnezij 2 g/5 ml
Metamizole Sodium Monohydrate 527mg Tablet, Pitofenone Hydrochloride 5.25mg Tablet, Fenpiverinium Bromide 0.1mg Tablet
Metamizolnatrij hidrat 527 mg tableta; pitofenonklorid 5,25 mg tableta; fenpiverinijev bromid 0,1 mg tableta
Metamizole Magnesium 500mg Capsule
Metamizolmagnezij 500 mg kapsula
Metamizole Sodium 500mg Sachet, Caffeine 50mg Sachet
Metamizolnatrij 500 mg vrećica; kofein 50 mg vrećica
Hydrochloride 2mg/ml, Fenpiverinium Bromide 0.02mg/ml, Metamizole Sodium 500mg/ml
Pitofenonklorid 2 mg/ml; fenpiverinijev bromid 0,02 mg/ml; metamizolnatrij 500 mg/ml
Metamizole Sodium Monohydrate 2,5 g/5 ml
Metamizolnatrij hidrat 2,5 g/5 ml
Pharma Gmbh Metamilan
G.L. Pharma Gmbh Metamilan
Metamizole Sodium 200mg Suppository
Metamizolnatrij 200 mg čepić
Metamizole 575mg Capsule
Metamizol 575 mg kapsula
Metamizole Sodium Monohydrate 500mg/ml, Pitofenone Hydrochloride 5mg/ml
Metamizolnatrij hidrat 500 mg/ml; pitofenonklorid 5 mg/ml
Metamizol Will-Pharma Metamizole Sodium Monohydrate 500mg/ml
Metamizol Will-Pharma Metamizolnatrij hidrat 500 mg/ml
Metamizol Normon Metamizole Magnesium 575mg Capsule
Metamizol Normon Metamizolmagnezij 575 mg kapsula
Cyanocobalamin 0.5mg Tablet, Metamizole Sodium 500mg Tablet, Thiamine Nitrate 75mg Tablet, Pyridoxine Hydrochloride 50mg Tablet
Cijanokobalamin 0,5 mg tableta; metamizolnatrij 500 mg tableta; tiaminnitrat 75 mg tableta; piridoksinklorid 50 mg tableta
Hydrochloride 2mg/ml, Fenpiverinium Bromide 0.02mg/ml
Metamizolnatrij hidrat 0,5 g/ml; pitofenonklorid 2 mg/ml; fenpiverinijev bromid 0,02 mg/ml
Pitofenone Hydrochloride 5mg, Metamizole Sodium 500mg
Pitofenonklorid 5 mg; metamizolnatrij 500 mg
Metamizole Magnesium 2000mg /5ml
Metamizolmagnezij 2000 mg/5 ml
Buscapina Compositum Metamizole Sodium 2.5g/5ml, Hyoscine
Buscapina Compositum Metamizolnatrij 2,5 g/5 ml; hioscinijev butilbromid 0,02 g/5 ml
Metamizole Sodium 100mg Suppository
Metamizolnatrij 100 mg čepić
Metamizole Magnesium 500mg Sachet
Metamizolmagnezij 500 mg vrećica
Metamizole Sodium 500g/ml
Metamizolnatrij 500 g/ml
Metamizol Heumann Metamizole Sodium Monohydrate 500mg/ml
Metamizol Heumann Metamizolnatrij hidrat 500 mg/ml